Global Rabies Diagnostics Market Size, Share, By Diagnostic Method (Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, and Serology Tests), By Technology (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, and Others), By End User (Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, and Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 - 2035.

Global Rabies Diagnostics Market Insights and Forecasts to 2035

• The Global Rabies Diagnostics Market Size Was Estimated at USD 2.24 billion in 2025
• The Market Size is Expected to Grow at a CAGR of around 5.06% from 2026 to 2035
• The Worldwide Rabies Diagnostics Market Size is Expected to Reach USD 3.67 billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights, the global rabies diagnostics market size was worth around USD 2.24 billion in 2025 and is predicted to grow to around USD 3.67 billion by 2035 with a compound annual growth rate (CAGR) of 5.06% from 2026 to 2035. The global rabies diagnostics market is driven by increasing prevalence of rabies infections, rising awareness regarding early disease detection, growing government surveillance programs, expanding veterinary healthcare infrastructure, and technological advancements in rapid diagnostic testing and molecular diagnostic techniques for accurate and timely diagnosis.

Market Overview

The global rabies diagnostics market represents an industry concerned with products and technologies employed for the detection of rabies infection in humans and animals via laboratory diagnostics, antigen detection, molecular diagnostics, and serological tests. Factors contributing to the market's development include the high prevalence of the rabies infection in developing countries, increasing awareness of zoonotic diseases, and rising demand for fast and precise diagnostics. In October 2025, the National Centre for Disease Control (NCDC) disclosed that the Indian government allocated approximately rupees 748 crore under the National Rabies Control Programme over five years to strengthen rabies prevention, laboratory support, post-exposure prophylaxis, and disease surveillance activities. Initiatives of government institutions related to mass vaccinations and rabies surveillance, along with funding from public organizations engaged in health care activities, facilitate market growth even further. One of the main trends observed in the market involves the growing use of rapid diagnostic tests and point-of-care testing systems aimed at providing fast diagnosis of the disease. Technical innovations involving the introduction of new PCR-based testing, immunofluorescent assays, and advanced portable devices contribute to this process. In June 2024, the World Health Organization (WHO), Gavi, and United Against Rabies announced investment support for human rabies vaccines across more than 50 countries to strengthen rabies prevention, surveillance, and diagnostic accessibility in high-burden regions. The potential for investments into veterinary infrastructure development and emerging markets presents ample opportunities for participants in the industry in the coming years.

Report Coverage

This research report categorizes the global rabies diagnostics market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth in drivers, opportunities, and challenges influencing the global rabies diagnostics market. recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the rabies diagnostics market.

The global market growth for rabies diagnostics is mainly due to the rising occurrence of rabies infection among people and animals in the Asia-Pacific and African regions with high stray dog populations. The growing need for early diagnosis and treatment has prompted increased use of new diagnostic methods. There are several government and international health organization efforts to promote rabies control, vaccination programs, and surveillance activities. Increasing investment in veterinary care facilities and development of more animal disease diagnostic tools are some other factors responsible for market expansion. Innovations in molecular diagnostic techniques such as real-time polymerase chain reaction and rapid antigen tests are also playing a significant role in market growth. Increased emphasis on preventing zoonotic diseases will continue to drive the market growth in the coming years.

Restraining Factors

The restricting factor in the global rabies diagnostics market is the scarcity of modern diagnostic tools in underdeveloped and rural areas where rabies is commonly found. The expensive nature of diagnostic techniques used for diagnosing rabies poses a challenge in their implementation in underdeveloped nations. Insufficient knowledge about the prompt detection of rabies and inadequate healthcare services further restrain the market from growing. Furthermore, the delay in sample collection and lack of competent healthcare professionals adversely impact the effectiveness of diagnostic procedures. The regulatory issues that come up due to diagnosis approval along with the absence of consistent reporting of diseases in various nations are other factors that restrict the market growth.

Market Segmentation

The global rabies diagnostics market share is classified into diagnostic method, technology, and end user.

• The fluorescent antibody test segment accounted for the largest share in 2025, approximately 38%, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the diagnostic method, the global rabies diagnostics market is divided into fluorescent antibody test, immunohistochemical test, amplification methods, histologic examination, and serology tests. Among these, the fluorescent antibody test segment accounted for the largest share in 2025, approximately 38%, and is anticipated to grow at a significant CAGR during the forecast period. This is because of high accuracy, rapid detection capability, and widespread acceptance as the standard method for rabies confirmation. The test provides reliable and quick results, which is essential for timely disease management and outbreak control. Increasing rabies surveillance programs, growing veterinary diagnostic activities, and rising awareness regarding zoonotic diseases have further supported segment growth. In addition, advancements in fluorescence microscopy technologies and improved laboratory infrastructure in developing regions are boosting adoption. Strong support from public health organizations and government rabies control initiatives also contributes to the segment’s market leadership.

The PCR segment accounted for the highest market revenue in 2025, approximately 41%, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the technology, the global rabies diagnostics market is divided into ELISA/immunohistochemistry, chromatography techniques, PCR, and others. Among these, the PCR segment accounted for the highest market revenue in 2025, approximately 41%, and is anticipated to grow at a significant CAGR during the forecast period. This is due to high sensitivity, specificity, and ability to detect rabies viral RNA at early stages of infection. PCR technology provides rapid and highly accurate results, making it widely preferred in advanced diagnostic laboratories and research institutions. Increasing adoption of molecular diagnostic techniques, rising demand for reliable disease confirmation, and expanding rabies surveillance programs have further accelerated segment growth. Technological advancements in real-time PCR systems and automated testing platforms are improving diagnostic efficiency and turnaround time. In addition, growing healthcare investments and strengthening laboratory infrastructure in emerging economies are supporting the increasing use of PCR-based rabies diagnostics.

• The hospital segment dominated the market in 2025, approximately 46%, and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the global rabies diagnostics market is divided into hospital, diagnostic centers, cancer palliative care clinics, and pharmacies. Among these, the hospital segment dominated the market in 2025, approximately 46%, and is projected to grow at a substantial CAGR during the forecast period. The dominance is driven by the high availability of advanced diagnostic equipment, skilled healthcare professionals, and specialized laboratory facilities for accurate rabies detection. Hospitals serve as primary healthcare centers for emergency treatment, disease diagnosis, and post-exposure prophylaxis in rabies cases. Increasing patient admissions related to animal bites and rising awareness regarding early diagnosis have further boosted demand for hospital-based diagnostic services. In addition, growing healthcare investments, expanding hospital infrastructure, and the adoption of advanced molecular diagnostic technologies are supporting segment growth. Strong government support for infectious disease management programs also contributes to the hospital segment’s leading market position.

Regional Segment Analysis of the Global Rabies Diagnostics Market

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global rabies diagnostics market over the predicted timeframe.

North America is anticipated to hold the largest share of the global rabies diagnostics market over the predicted timeframe, approximately 45% market share. The growth is driven by the advanced healthcare and veterinary diagnostic infrastructure. The region has a strong presence of leading diagnostic companies, research institutions, and public health organizations actively involved in infectious disease monitoring and rabies surveillance programs. High adoption of molecular diagnostic technologies, including PCR and rapid antigen testing, further supports market growth. In addition, increasing government funding for zoonotic disease prevention, growing awareness regarding early disease diagnosis, and established laboratory networks contribute to the region’s dominant position. The United States and Canada continue to invest heavily in animal healthcare, disease control initiatives, and advanced diagnostic research activities.

Asia Pacific expected to grow at the fastest rate during the forecast period, with approximately 26% of the market share. The market growth is fueled by the high prevalence of rabies cases across developing countries such as India, China, Indonesia, and the Philippines. Rising stray dog populations, increasing awareness regarding zoonotic disease prevention, and growing demand for early disease diagnosis are major factors supporting market expansion. Governments across the region are actively implementing rabies vaccination campaigns, surveillance programs, and healthcare improvement initiatives to reduce rabies-related deaths. Expanding healthcare infrastructure, improving access to diagnostic technologies, and increasing investments in veterinary healthcare are also accelerating market growth. Rapid urbanization and rising public health expenditure further contribute to the growing adoption of rabies diagnostic solutions.

Competitive Analysis

The report offers the appropriate analysis of the key organizations/companies involved within the global rabies diagnostics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Thermo Fisher Scientific
• Bio-Rad Laboratories
• QIAGEN N.V.
• Hoffmann-La Roche Ltd
• Abbott Laboratories
• Merck KGaA
• Becton, Dickinson and Company
• Danaher Corporation
• Siemens Healthineers AG
• BioMérieux SA
• Agilent Technologies
• Promega Corporation
• PerkinElmer Inc.
• ZEISS Group
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In February 2025, Bio-Rad Laboratories announced its planned acquisition of Stilla Technologies to strengthen its digital PCR and clinical diagnostics capabilities, supporting advanced infectious disease diagnostics.

• In September 2024, QIAGEN launched more than 100 new QIAcuity digital PCR assays for infectious disease surveillance and microbial detection applications, supporting advanced molecular diagnostic testing.

• In September 2024, Hoffmann-La Roche Ltd launched the cobas Respiratory flex test using its proprietary TAGS technology for simultaneous detection of multiple respiratory viruses, strengthening its molecular infectious disease diagnostics portfolio.

• In March 2024, Agilent Technologies continued expanding its diagnostics and genomics research capabilities through advanced PCR and molecular analysis solutions designed for infectious disease and pathogen detection applications.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the global rabies diagnostics market based on the below-mentioned segments:

Global Rabies Diagnostics Market, By Diagnostic Method

• Fluorescent Antibody Test
• Immunohistochemical Test
• Amplification Methods
• Histologic Examination
• Serology Tests

Global Rabies Diagnostics Market, By Technology

• ELISA/Immunohistochemistry
• Chromatography Techniques
• PCR
• Others

Global Rabies Diagnostics Market, By End User

• Hospital
• Diagnostic Centers
• Cancer Palliative Care Clinics
• Pharmacies

Global Rabies Diagnostics Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa